ViCentra today announced its plans to kick off the launch of its next-generation hybrid closed-loop automated insulin delivery system. The company plans to launch the new system, utilizing its Kaleido patch pump, in Germany and the Netherlands in early 2026. Launch plans come on the heels of CE mark approval for Diabeloop’s DBLG2 algorithm, which […]
Diabeloop
Diabeloop launches insulin delivery algorithm in Germany
Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in Germany. The companies distribute their automated insulin delivery offering through Mediq, a leading European diabetes provider. Mediq serves as the exclusive distributor for the DBLG1 system and the Dana-i pump by Sooil. Paris-based Diabeloop develops therapeutic artificial […]
Diabeloop study highlights disparities in insulin requirements between sexes
Diabeloop reported results from a real-world study that demonstrated important differences between males and females in insulin requirements. The study evaluated more than 9,000 adults with type 1 diabetes across Europe. It utilized data from patients using the Diabeloop Generation 1 (DBLG1) hybrid closed-loop insulin delivery device. Investigators published findings in the Journal of Diabetes […]
ViCentra launches hybrid closed-loop insulin system with Dexcom G6
ViCentra announced today that it launched a hybrid closed-loop automated insulin delivery system that uses the Dexcom G6 CGM. Utrecht, The Netherlands-based ViCentra designed the system to deliver insulin through its Kaleido insulin pump. The Diabeloop DBLG1 algorithm receives input from Dexcom’s G6 continuous glucose monitor. Together, they form an artificial pancreas offering flexible self […]
Diabeloop, EOFlow partner on wearable automated insulin delivery in Europe
Diabeloop and EOFlow announced that they partnered to offer the latter’s EOPatch system with automated insulin delivery in Europe. This partnership combines the EOPatch, a third-party continuous glucose monitor (CGM) and Diabeloop’s automated insulin delivery algorithm. They all integrate into Diabeloop’s currently under-development smartphone app. Paris-based Diabeloop said in a news release that they also […]
Study backs automated insulin delivery system from Diabeloop
Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system. Paris-based Diabeloop evaluated DBLG1 in a large, multi-country patient cohort. Results demonstrated constant improvement in time in range and time in hypoglycemia remaining significantly low. The company said in a news release that the results, combined with trust in its algorithm, […]
Diabeloop, SOOIL partner on automated insulin delivery technology
Diabeloop announced today that it entered into global development and commercial agreements with insulin delivery technology developer SOOIL. Paris-based Diabeloop, which develops therapeutic artificial intelligence (AI) applied to insulin delivery, and SOOIL will pursue and expand upon technical integration between their platforms, building on cooperation that was initiated in February 2020. According to a news […]
Diabeloop raises $74.9M Series C
Diabeloop announced today that it raised approximately $74.9 million (€70 million) in a Series C financing round. LBO France, a private equity player, led the financing round, while Terumo — with which Diabeloop has partnered since 2020 — also participated in the round. Innovacom joined LBO France and Terumo as new investors, according to a […]
CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022
All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out […]
Study results show improved time in range with Diabeloop automated insulin delivery system
Diabeloop announced today that study data support the use of its DBLG1 hybrid closed-loop automated insulin delivery system. Paris-based Diabeloop’s real-life German cohort data, presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference in Barcelona, show a constant improvement in time in range (70-180 mg/dL) combined with a significant reduction of hypoglycemia. According […]
